3D Bioprinting also known as additive manufacturing is used to make three dimensional solid objects from a digital file which is achieved by using additive processes.
3D Bioprinting technology developed from prototyping in various applications for development of actual usable parts and products. 3D bioprinting market facilitates the opportunities for prosthesis, dental implants, hearing aids, contact lenses, hips implant, custom made knee and etc. that are customized and personalized according to the individual, one of the advances of 3D printing is known as bio-printing or the ability to print living tissues. 3D printer use “bio-ink,” a blend of living cells, the bio-printer create a structure from these cells, layer by layer, to create human tissue. By the help of 3D bioprinting physicians can use patient-specific data to capture, modify and at last apply various physical solutions of all shapes and sizes to the patient, without such application or technology, personalized treatment to patient would be difficult, as patients will need unique parts that can be rapidly and simply manufactured. It’s also helps to reduce surgery cost, time, trauma and healing period which is beneficial for both patient and surgeon.
3D Bioprinting Market: Drivers and Restraints
Presently, global 3D healthcare printing market is driven by the advancement in technology, increase in the percentage of aging population as old age is considered as the high risk factor for the development of various disorders, improvement in the healthcare infrastructure, and increase in the investment in research and development sector.
Technological advances in this dynamic industry are ever ongoing applications of additive manufacturing in healthcare are expanding. However, lack of skilled professional act as a major barrier for 3D healthcare printing global market.
Request For Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-808
3D Bioprinting Market: Segmentation
3D bioprinting global market is segmented into following types:
- Electron beam melting
- Laser beam melting
- Stereo lithography
- Digital light processing
- Two-photon polymerization
- Droplet disposition
- Inkjet printing
- Fused disposition modeling
- Multi-phase jet solidification
3D Bioprinting Market: Overview
With rapid technological advancement and increase in the investment in R&D sector, the global 3D bioprinting market is expected to have a healthy growth rate in the forecast period (2015-2025).
3D bioprinting global market is expected to witness significant growth, owing to intervention of government for improving healthcare infrastructure and increasing investments in R&D sector. In addition, healthcare professionals increasingly explore 3D bioprinting because it reduces the risks associated with anesthesia during long surgeries and improves healthcare.
3D Bioprinting Market: Region-wise Outlook
Depending on geographic region, global 3D bioprinting market is segmented into seven key regions: North America, South America, Eastern Europe, Western Europe, Asia Pacific, Japan, and Middle East & Africa.
North America is the leading market for 3D bioprinting whereas Europe is expected to capture the large market shares followed by Asia Pacific region where the market is expected to grow due to rapid technological innovations, huge investment on research and development in these regions, large consumer base, and high disposable income.
Request For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-808
3D Bioprinting Market: Key Players
Some of the key participating global players in 3D bioprinting global market are Stratasys Ltd., 3D Systems, Inc., Materialise NV, Organovo Holdings Inc., SOLS Systems, Youbionic, The Pexion Group, Oceanz 3D printing & Additive Manufacturing, and others.